Baird Maintains Outperform on Medpace Holdings, Lowers Price Target to $477

Benzinga Newsdesk www.benzinga.com Negative 94.1%

Neg 94.1% Neu 0% Pos 0%

Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $565 to $477.